Heart Failure Hospitalization
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB15456 | Vericiguat | A soluble guanylate cyclase stimulator used to reduce heart failure-related hospitalization and cardiovascular death in patients with chronic systolic heart failure. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB15456 | Vericiguat | UDP-glucuronosyltransferase 1-9 | enzyme |
| DB15456 | Vericiguat | UDP-glucuronosyltransferase 1-1 | enzyme |
| DB15456 | Vericiguat | P-glycoprotein 1 | transporter |
| DB15456 | Vericiguat | ATP-binding cassette sub-family G member 2 | transporter |
| DB15456 | Vericiguat | Serum albumin | carrier |
| DB15456 | Vericiguat | Guanylate cyclase soluble subunit beta-1 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00169 | Cholecalciferol | 4 | Recruiting | 1 |